N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide

C45H51N11O5 — CID 177209137

IUPACN-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide
SMILESCOc1cc(N2CCC(CN3CCC(n4cc5cc(NC(=O)c6cccc7ncnn67)c(N6CCCCC6)cc5n4)CC3)CC2)ccc1C(=O)N[C@H]1CCC(=C=O)NC1=C=O
InChIInChI=1S/C45H51N11O5/c1-61-42-23-34(9-10-35(42)44(59)49-36-11-8-32(27-57)48-39(36)28-58)53-20-12-30(13-21-53)25-52-18-14-33(15-19-52)55-26-31-22-38(41(24-37(31)51-55)54-16-3-2-4-17-54)50-45(60)40-6-5-7-43-46-29-47-56(40)43/h5-7,9-10,22-24,26,29-30,33,36,48H,2-4,8,11-21,25H2,1H3,(H,49,59)(H,50,60)/t36-/m0/s1
InChIKeyQTEQCPFCMYGNAW-BHVANESWSA-N
MW825.97 g/mol
LogP4.80
Rot. Bonds10

About N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide

N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide (PubChem CID 177209137) has the molecular formula C45H51N11O5 and a molecular weight of 825.97 g/mol. Its IUPAC name is N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide.

Molecular Properties

Compound NameN-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide
PubChem CID177209137
Molecular FormulaC45H51N11O5
Molecular Weight825.97 g/mol
Exact Mass825.41
IUPAC NameN-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide
SMILESCOc1cc(N2CCC(CN3CCC(n4cc5cc(NC(=O)c6cccc7ncnn67)c(N6CCCCC6)cc5n4)CC3)CC2)ccc1C(=O)N[C@H]1CCC(=C=O)NC1=C=O
InChIInChI=1S/C45H51N11O5/c1-61-42-23-34(9-10-35(42)44(59)49-36-11-8-32(27-57)48-39(36)28-58)53-20-12-30(13-21-53)25-52-18-14-33(15-19-52)55-26-31-22-38(41(24-37(31)51-55)54-16-3-2-4-17-54)50-45(60)40-6-5-7-43-46-29-47-56(40)43/h5-7,9-10,22-24,26,29-30,33,36,48H,2-4,8,11-21,25H2,1H3,(H,49,59)(H,50,60)/t36-/m0/s1
InChIKeyQTEQCPFCMYGNAW-BHVANESWSA-N
XLogP4.80
TPSA171.33 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds10
Heavy Atoms61
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500825.97
LogP ≤ 54.80
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'ketene', 'substructure': 'N/A'}

Analyze N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide?
The IUPAC name of N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide (CID 177209137) is N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide.
What is the SMILES notation for N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide?
The canonical SMILES for N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide is COc1cc(N2CCC(CN3CCC(n4cc5cc(NC(=O)c6cccc7ncnn67)c(N6CCCCC6)cc5n4)CC3)CC2)ccc1C(=O)N[C@H]1CCC(=C=O)NC1=C=O.
What is the InChIKey of N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide?
The InChIKey is QTEQCPFCMYGNAW-BHVANESWSA-N. The full InChI is InChI=1S/C45H51N11O5/c1-61-42-23-34(9-10-35(42)44(59)49-36-11-8-32(27-57)48-39(36)28-58)53-20-12-30(13-21-53)25-52-18-14-33(15-19-52)55-26-31-22-38(41(24-37(31)51-55)54-16-3-2-4-17-54)50-45(60)40-6-5-7-43-46-29-47-56(40)43/h5-7,9-10,22-24,26,29-30,33,36,48H,2-4,8,11-21,25H2,1H3,(H,49,59)(H,50,60)/t36-/m0/s1.
What are the key properties of N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide?
N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide has a molecular weight of 825.97 g/mol, XLogP of 4.80, 10 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[1-[[1-[4-[[(3S)-2,6-bis(oxomethylidene)piperidin-3-yl]carbamoyl]-3-methoxyphenyl]piperidin-4-yl]methyl]piperidin-4-yl]-6-piperidin-1-ylindazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine-5-carboxamide is sourced from PubChem (CID 177209137), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).